Cargando...

Regadenoson, a Novel Pharmacologic Stress Agent for Use in Myocardial Perfusion Imaging, Does Not Have a Direct Effect on the QT Interval in Conscious Dogs

Our goal was to determine the effect of regadenoson (a novel A(2A) adenosine receptor agonist) on the QT interval in conscious dogs. Eleven mongrel dogs were chronically instrumented for measurements of blood pressure and ECG. Regadenoson (2.5, 5 and 10 μg/kg, IV) caused a dose-dependent QT interval...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cardiovasc Pharmacol
Autores principales: Zhao, Gong, Serpllion, Sabrina, Shryock, John, Messina, Eric, Xu, Xiaobin, Ochoa, Manuel, Belardinelli, Luiz, Hintze, Thomas H
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774219/
https://ncbi.nlm.nih.gov/pubmed/19033827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0b013e31818e035b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!